June 25 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® ANNOUNCES INVESTIGATOR SPONSORED PHASE 2 TRIAL EVALUATING PELAREOREP-ANTI-PD-1 COMBINATION TREATMENT IN TRIPLE-NEGATIVE BREAST CANCER
June 25 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® ANNOUNCES INVESTIGATOR SPONSORED PHASE 2 TRIAL EVALUATING PELAREOREP-ANTI-PD-1 COMBINATION TREATMENT IN TRIPLE-NEGATIVE BREAST CANCER